WILZA WANESSA MELO FRANCA

Ms. WILZA WANESSA MELO FRANCA

Tropical medicine, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2022 in Acta Tropica
Verified
Journal Article
Closed access
CCClênio Silva Cruz
Clênio Silva Cruz
WFWILZA WANESSA MELO FRANCA
WILZA WANESSA MELO FRANCA
HAHallysson Douglas Andrade de Arújo
Hallysson Douglas Andrade de Arújo
EXEulália Camelo Pessoa Azevedo Ximenes
Eulália Camelo Pessoa Azevedo Ximenes
VSValdênia Maria de Souza
Valdênia Maria de Souza
VCVláudia Maria Assis Costa
Vláudia Maria Assis Costa

20 September 2022 in Pest Management Science
Verified
Journal Article
Closed access
WFWILZA WANESSA MELO FRANCA
WILZA WANESSA MELO FRANCA
ASAdriana Maria da Silva
Adriana Maria da Silva
EDEmily Gabriele Marques Diniz
Emily Gabriele Marques Diniz
HSHianna Arely Milca Fagundes Silva
Hianna Arely Milca Fagundes Silva
DPDewson Rocha Pereira
Dewson Rocha Pereira
AAAndré de Lima Aires
André de Lima Aires
1

22 August 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
LSLucas M. N. Silva
Lucas M. N. Silva
WFWILZA WANESSA MELO FRANCA
WILZA WANESSA MELO FRANCA
VSVictor H. B. Santos
Victor H. B. Santos
RSRenan A. F. Souza
Renan A. F. Souza
ASAdriana M. Silva
Adriana M. Silva
MAMônica Camelo Pessoa de Azevedo Albuquerque
Mônica Camelo Pessoa de Azevedo Albuquerque
Schistosomiasis, a potentially fatal chronic disease whose etiological agents are blood trematode worms of the genus Schistosoma spp., is one of the most prevalent and debilitating neglected diseases. The treatment of schistosomiasis depends exclusively on praziquantel (PZQ), a drug that has been used since the 1970s and that already has reports of reduced therapeutic efficacy, related with the development of Schistosoma-resistant or -tolerant strains. Therefore, the search for new therapeutic alternatives is an urgent need. Plumbagin (PLUM), a naphthoquinone isolated from the roots of plants of the genus Plumbago, has aroused interest in research due to its antiparasitic properties against protozoa and helminths. Here, we evaluated the in vivo schistosomicidal potential of PLUM against Schistosoma mansoni and the in silico pharmacokinetic parameters. ADMET parameters and oral bioavailability were evaluated using the PkCSM and SwissADME platforms, respectively. The study was carried out with five groups of infected mice and divided as follows: an untreated control group, a control group treated with PZQ, and three groups treated orally with 8, 16, or 32 mg/kg of PLUM. After treatment, the Kato–Katz technique was performed to evaluate a quantity of eggs in the feces (EPG). The animals were euthanized for worm recovery, intestine samples were collected to evaluate the oviposition pattern, the load of eggs was determined on the hepatic and intestinal tissues and for the histopathological and histomorphometric evaluation of tissue and hepatic granulomas. PLUM reduced EPG by 65.27, 70.52, and 82.49%, reduced the total worm load by 46.7, 55.25, and 72.4%, and the female worm load by 44.01, 52.76, and 71.16%, for doses of 8, 16, and 32 mg/kg, respectively. PLUM also significantly reduced the number of immature eggs and increased the number of dead eggs in the oogram. A reduction of 36.11, 46.46, and 64.14% in eggs in the hepatic tissue, and 57.22, 65.18, and 80.5% in the intestinal tissue were also observed at doses of 8, 16, and 32 mg/kg, respectively. At all doses, PLUM demonstrated an effect on the histopathological and histomorphometric parameters of the hepatic granuloma, with a reduction of 41.11, 48.47, and 70.55% in the numerical density of the granulomas and 49.56, 57.63, and 71.21% in the volume, respectively. PLUM presented itself as a promising in vivo antiparasitic candidate against S. mansoni, acting not only on parasitological parameters but also on hepatic granuloma. Furthermore, in silico, PLUM showed good predictive pharmacokinetic profiles by ADMET.

6 September 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
WFWILZA WANESSA MELO FRANCA
WILZA WANESSA MELO FRANCA
SFSérgio D. Magalhães Filho
Sérgio D. Magalhães Filho
LCLucas Andrade Oliveira Cavalcante
Lucas Andrade Oliveira Cavalcante
MGMary Angela Aranda de Souza Gomes
Mary Angela Aranda de Souza Gomes
MGMaria Tairla Viana Gonçalves
Maria Tairla Viana Gonçalves
JVJeymesson Vieira
Jeymesson Vieira
Rhizophora mangle is commonly used in traditional medicine to treat infections, reduce inflammation, and promote healing. This study aimed to analyze the phytochemical profile of the methanolic extract of R. mangle leaves (MELRm) and evaluate its in vitro schistosomicidal activity against Schistosoma mansoni as well as its cytotoxicity. Plant material was collected in Itamaracá City, Pernambuco, Brazil. The extract was analyzed using UV/Vis spectrophotometry and high-performance liquid chromatography (HPLC). The motility, mortality, and cell viability of adult worms were assessed in a schistosomicidal assay, while cytotoxicity was evaluated through a colorimetric assay with MTT on RAW 264.7 cells. The primary compounds identified in MELRm were phenolic compounds. In the schistosomicidal assay, all concentrations of MELRs induced changes in the motility of adult worms. At a concentration of 400 μg/mL, MELRs resulted in 56.25% mortality after 72 h of incubation. After 120 h, mortality rates of 75%, 62.5%, and 50% were observed at MELRm concentrations of 400, 200, and 100 μg/mL, respectively. No eggs were detected at any MELRm concentration. MELRs did not show cytotoxicity towards RAW 264.7 cells at the concentrations tested. These results indicate that MELRs demonstrate schistosomicidal activity in vitro, suggesting they are promising candidates for in vivo studies.

4 March 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
JRJoão Victor Ritinto da Rocha
João Victor Ritinto da Rocha
WFWILZA WANESSA MELO FRANCA
WILZA WANESSA MELO FRANCA
AMArthur Machado
Arthur Machado
LCLucas Andrade Oliveira Cavalcante
Lucas Andrade Oliveira Cavalcante
MGMaria Tairla Viana Gonçalves
Maria Tairla Viana Gonçalves
Andre de Lima AiresAndre de Lima Aires
Andre de Lima Aires
Background: Schistosomiasis affects more than 250 million people, and praziquantel remains the only drug available for treatment; however, its activity is restricted to adult worms. Previously, our group evaluated six thiazole derivatives (PBT1–PBT6) in vitro against adult Schistosoma mansoni, identifying PBT2, PBT5, and PBT6 as the most active compounds. The present study aimed to evaluate the in vitro activity of PBT2, PBT5, and PBT6 against schistosomula and juvenile worms, as well as their in vivo efficacy against adult S. mansoni. Methods: Mechanically transformed schistosomula and juvenile worms recovered from mice (21 days post-infection) were incubated with the compounds (12.5–200 μM). Cytotoxicity was assessed using murine splenocytes and peritoneal macrophages exposed to the same concentration range. For in vivo evaluation, infected mice were orally treated with compounds (50, 100, or 200 mg/kg) for five consecutive days. Results: All compounds induced 100% mortality in schistosomula and juvenile worms within 3 h of exposure at 100 and 200 μM. Parasite cell viability was markedly reduced (>90%) at concentrations between 50 and 200 μM. The LC50 values ranged from 15.3 to 30.9 μM for schistosomula and from 27.8 to 34.9 μM for juvenile worms, with low cytotoxicity observed in mammalian cells (CC50 ≥ 193.9 μM). In vivo treatment resulted in significant reductions in fecal egg counts (~80% at 200 mg/kg), total worm burden (~60%), and egg loads in liver and intestinal tissues, in addition to an increased proportion of dead eggs in the intestine. Conclusions: The evaluated thiazole derivatives demonstrated potent in vitro activity against immature stages of S. mansoni and significant in vivo efficacy against adult parasites, accompanied by favorable changes in key parasitological parameters. These findings reinforce the potential of thiazole-based compounds as promising multistage schistosomicidal candidates.

19 March 2025 in Revista Pleiade
Verified
Journal Article
Open access
PDF file
WFWILZA WANESSA MELO FRANCA
WILZA WANESSA MELO FRANCA
A distribuição geográfica da Rhizophora mangle coincide com a localização da distribuição dos casos de esquistossomose no Brasil, indicando o potencial da espécie como fonte de substâncias com atividade esquistossomicida. O objetivo do presente trabalho foi avaliar a atividade do extrato metanólico de R. mangle na motilidade, sobrevivência e viabilidade de vermes adultos de Schistosoma mansoni in vitro, apresentando atividade promissora em todos os parâmetros avaliados.